Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jason Farrar

Concepts (449)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute
15
2024
180
3.170
Why?
Anemia, Diamond-Blackfan
13
2024
13
2.730
Why?
Mutation
15
2023
1275
1.730
Why?
Pain Measurement
17
2023
271
1.710
Why?
Clinical Trials as Topic
18
2018
488
1.540
Why?
Ribosomal Proteins
9
2021
23
1.490
Why?
Analgesics
12
2018
117
1.350
Why?
Pain
14
2023
386
1.310
Why?
Midazolam
1
2024
37
0.910
Why?
Hypnotics and Sedatives
1
2024
75
0.870
Why?
Humans
101
2025
50419
0.860
Why?
Electroacupuncture
4
2015
6
0.840
Why?
Neurosurgical Procedures
1
2024
126
0.830
Why?
Breast Neoplasms
5
2021
1198
0.830
Why?
Gene Expression Profiling
6
2023
1020
0.800
Why?
Wounds and Injuries
2
2025
288
0.760
Why?
Rhabdomyosarcoma, Alveolar
1
2021
8
0.750
Why?
Li-Fraumeni Syndrome
1
2021
11
0.750
Why?
Testosterone
6
2018
145
0.740
Why?
Enoxaparin
1
2021
31
0.720
Why?
Female
45
2025
27053
0.690
Why?
Aged
29
2025
9738
0.670
Why?
Venous Thromboembolism
1
2021
74
0.670
Why?
Chronic Pain
6
2023
183
0.660
Why?
Tumor Suppressor Protein p53
1
2021
212
0.660
Why?
Male
45
2025
25866
0.640
Why?
Diabetic Neuropathies
3
2016
57
0.630
Why?
Critical Illness
4
2025
302
0.630
Why?
Neuralgia
3
2018
67
0.620
Why?
Body Weight
1
2021
517
0.620
Why?
Cyclohexanecarboxylic Acids
2
2015
20
0.600
Why?
Amines
2
2015
42
0.590
Why?
gamma-Aminobutyric Acid
2
2015
64
0.580
Why?
Fatigue
4
2019
127
0.550
Why?
RNA Processing, Post-Transcriptional
3
2014
23
0.550
Why?
Neuralgia, Postherpetic
2
2014
3
0.540
Why?
Middle Aged
24
2025
12579
0.530
Why?
Treatment Outcome
21
2023
5265
0.530
Why?
Research Design
8
2016
348
0.530
Why?
Child, Preschool
20
2021
3953
0.530
Why?
Acute Pain
2
2016
11
0.510
Why?
Adult
23
2025
13561
0.490
Why?
Hot Flashes
1
2015
7
0.490
Why?
Spinal Stenosis
1
2015
13
0.490
Why?
GATA1 Transcription Factor
2
2017
7
0.480
Why?
Hormone Replacement Therapy
6
2018
33
0.480
Why?
Chemotherapy, Adjuvant
1
2015
119
0.480
Why?
Infant
17
2021
3648
0.470
Why?
Oncogene Proteins, Fusion
4
2024
57
0.470
Why?
RNA, Ribosomal
1
2014
17
0.460
Why?
RNA Precursors
1
2014
8
0.460
Why?
Lumbar Vertebrae
1
2015
102
0.460
Why?
Codon, Initiator
1
2014
1
0.450
Why?
Child
25
2025
6931
0.450
Why?
Bone Neoplasms
2
2023
178
0.440
Why?
Meningitis, Cryptococcal
2
2010
10
0.440
Why?
Point Mutation
1
2014
61
0.440
Why?
Pain Management
6
2016
180
0.440
Why?
Prognosis
6
2024
1974
0.380
Why?
Molar, Third
1
2011
4
0.380
Why?
Tooth Extraction
1
2011
7
0.380
Why?
Survivors
2
2015
126
0.370
Why?
Cryptococcus neoformans
2
2010
26
0.370
Why?
Tomography, Emission-Computed, Single-Photon
1
2011
52
0.370
Why?
Amplified Fragment Length Polymorphism Analysis
1
2010
3
0.360
Why?
Mycological Typing Techniques
1
2010
3
0.360
Why?
Cerebrovascular Circulation
1
2011
132
0.350
Why?
Sexual Behavior
3
2016
116
0.350
Why?
DNA, Fungal
1
2010
44
0.350
Why?
Gene Deletion
1
2011
260
0.350
Why?
Brain Mapping
1
2011
224
0.340
Why?
Pain, Postoperative
1
2011
163
0.340
Why?
Arthralgia
3
2014
45
0.330
Why?
Adolescent
16
2025
6453
0.330
Why?
Practice Guidelines as Topic
4
2015
473
0.330
Why?
Drug Resistance, Bacterial
2
2010
71
0.320
Why?
Biomedical Research
3
2015
243
0.320
Why?
Randomized Controlled Trials as Topic
6
2023
567
0.320
Why?
Dysentery, Bacillary
1
2009
2
0.310
Why?
Shigella
1
2009
4
0.310
Why?
Acupuncture Therapy
1
2009
4
0.310
Why?
Cephalosporins
1
2009
39
0.310
Why?
Intensive Care Units
3
2025
228
0.310
Why?
Osteoarthritis, Knee
2
2023
98
0.300
Why?
Dogs
1
2008
185
0.300
Why?
Vietnam
7
2010
27
0.300
Why?
Disability Evaluation
3
2019
92
0.290
Why?
Radiotherapy
1
2009
125
0.290
Why?
Double-Blind Method
7
2023
710
0.290
Why?
Quality of Life
8
2019
850
0.280
Why?
Severity of Illness Index
7
2024
976
0.280
Why?
Young Adult
11
2025
4075
0.280
Why?
DNA Methylation
6
2023
548
0.280
Why?
Health Status
2
2017
298
0.270
Why?
Sleep Initiation and Maintenance Disorders
1
2007
43
0.270
Why?
Anti-Inflammatory Agents
2
2019
165
0.270
Why?
Stress, Psychological
2
2014
268
0.270
Why?
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
2
2017
6
0.260
Why?
Prospective Studies
6
2024
2378
0.260
Why?
Disease Models, Animal
3
2021
1431
0.260
Why?
Aromatase Inhibitors
3
2014
17
0.250
Why?
Pain, Intractable
3
2011
9
0.250
Why?
Polymorphism, Single Nucleotide
4
2013
468
0.250
Why?
Anti-Bacterial Agents
2
2025
751
0.250
Why?
Aged, 80 and over
7
2024
3233
0.240
Why?
Exocrine Pancreatic Insufficiency
1
2025
4
0.240
Why?
Lipomatosis
1
2025
6
0.240
Why?
Bone Marrow Diseases
1
2025
11
0.240
Why?
Kidney Function Tests
1
2025
52
0.240
Why?
Oligonucleotide Array Sequence Analysis
3
2011
400
0.240
Why?
Age Factors
4
2021
1118
0.240
Why?
Creatinine
1
2025
142
0.230
Why?
Walking
2
2016
100
0.230
Why?
Pneumonia, Ventilator-Associated
1
2025
21
0.230
Why?
Nutritional Support
1
2024
35
0.230
Why?
Drug Resistance, Multiple, Bacterial
1
2025
63
0.230
Why?
Lymphoma
1
2025
66
0.230
Why?
Retrospective Studies
8
2025
6274
0.220
Why?
Terminal Care
1
2024
46
0.220
Why?
Cystitis, Interstitial
1
2023
11
0.220
Why?
Hemophilia A
1
2024
25
0.220
Why?
Neurodegenerative Diseases
1
2024
74
0.210
Why?
Gene Rearrangement
1
2024
63
0.210
Why?
Case-Control Studies
4
2017
1152
0.210
Why?
Neuromuscular Blockade
1
2023
15
0.210
Why?
Encephalitis, Japanese
1
2003
2
0.210
Why?
Cell Cycle Proteins
2
2021
163
0.210
Why?
Chromatography, High Pressure Liquid
1
2024
326
0.210
Why?
Consensus
1
2024
159
0.210
Why?
Tandem Mass Spectrometry
1
2024
238
0.210
Why?
Osteosarcoma
1
2023
45
0.210
Why?
Interferon-alpha
1
2003
48
0.200
Why?
Viruses
2
2015
21
0.200
Why?
Medicare
1
2024
247
0.200
Why?
Enteral Nutrition
1
2023
149
0.200
Why?
Chromosome Aberrations
3
2017
279
0.200
Why?
Azacitidine
2
2023
34
0.190
Why?
Blood Glucose
1
2024
447
0.190
Why?
Leukemia, Myelomonocytic, Juvenile
1
2022
14
0.190
Why?
Incidence
2
2025
1027
0.190
Why?
Antiviral Agents
1
2003
171
0.180
Why?
Cross-Sectional Studies
4
2019
1601
0.180
Why?
Drug Dosage Calculations
1
2021
11
0.180
Why?
Diabetes Mellitus
1
2024
281
0.180
Why?
Neoplasms, Second Primary
1
2022
74
0.180
Why?
Co-Repressor Proteins
1
2021
17
0.180
Why?
Neoplasms
2
2009
1248
0.180
Why?
Androgens
2
2018
71
0.180
Why?
Erythrocyte Transfusion
1
2021
52
0.180
Why?
Gene Regulatory Networks
1
2021
106
0.180
Why?
Placebos
4
2016
87
0.180
Why?
Chromosomal Proteins, Non-Histone
1
2021
36
0.180
Why?
Injury Severity Score
1
2021
165
0.170
Why?
B-Lymphocytes
1
2021
171
0.170
Why?
Kidney
1
2025
690
0.170
Why?
Registries
2
2018
565
0.170
Why?
Chromatin
1
2021
133
0.170
Why?
Leucine
1
2020
118
0.170
Why?
Evidence-Based Medicine
3
2011
254
0.160
Why?
Blood Transfusion
1
2020
123
0.160
Why?
MicroRNAs
2
2021
345
0.160
Why?
Systemic Vasculitis
1
2019
2
0.160
Why?
Dose-Response Relationship, Drug
2
2021
1369
0.160
Why?
Ribosomes
2
2009
21
0.160
Why?
Recurrence
2
2022
657
0.150
Why?
Sex Factors
1
2021
718
0.150
Why?
Controlled Clinical Trials as Topic
1
2018
22
0.150
Why?
Research Report
1
2018
16
0.150
Why?
DNA-Binding Proteins
1
2021
410
0.150
Why?
Risk Factors
3
2025
3712
0.150
Why?
Anxiety
2
2023
285
0.140
Why?
Feasibility Studies
3
2020
389
0.140
Why?
Induction Chemotherapy
1
2017
59
0.140
Why?
Sensory Thresholds
1
2017
18
0.140
Why?
Ribosome Subunits, Large, Eukaryotic
2
2014
2
0.140
Why?
Agammaglobulinemia
1
1996
9
0.140
Why?
X Chromosome
1
1996
12
0.140
Why?
United States
5
2024
5005
0.130
Why?
Genome, Human
2
2021
108
0.130
Why?
Infant, Newborn
4
2023
2752
0.130
Why?
Anemia
1
2017
67
0.130
Why?
Phenotype
3
2021
736
0.130
Why?
HIV Infections
2
2010
347
0.130
Why?
Receptors, Colony-Stimulating Factor
1
2016
1
0.130
Why?
Sexual Dysfunction, Physiological
1
2016
17
0.130
Why?
Hemoglobins
1
2017
112
0.130
Why?
CCAAT-Enhancer-Binding Proteins
1
2016
14
0.130
Why?
Cell Proliferation
4
2021
980
0.130
Why?
Animals
9
2023
13063
0.130
Why?
Inservice Training
1
2016
34
0.130
Why?
Neutropenia
1
1996
116
0.130
Why?
Health Planning Guidelines
2
2007
15
0.130
Why?
Low Back Pain
1
2016
28
0.130
Why?
Consensus Development Conferences as Topic
1
2015
13
0.120
Why?
Genotype
3
2013
525
0.120
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
568
0.120
Why?
DNA Copy Number Variations
1
2016
109
0.120
Why?
Needles
1
2015
25
0.120
Why?
Time Factors
5
2015
2933
0.120
Why?
Influenza A Virus, H5N1 Subtype
1
2015
1
0.120
Why?
Exercise Test
1
2015
131
0.120
Why?
Hypopituitarism
1
2014
17
0.120
Why?
Placebo Effect
1
2014
17
0.120
Why?
Intention to Treat Analysis
1
2014
28
0.120
Why?
Pilot Projects
2
2020
694
0.120
Why?
Ribosome Subunits, Small, Eukaryotic
1
2014
2
0.120
Why?
Gonadal Steroid Hormones
1
2014
41
0.120
Why?
K562 Cells
1
2014
40
0.110
Why?
Transcription Factors
3
2024
561
0.110
Why?
Virus Diseases
1
2015
42
0.110
Why?
Analgesics, Opioid
2
2012
577
0.110
Why?
Exercise
1
2018
513
0.110
Why?
Chromosome Mapping
3
2011
143
0.110
Why?
Skin
1
2017
382
0.110
Why?
Leukemia, Myeloid
1
2014
44
0.110
Why?
Molecular Epidemiology
2
2010
34
0.110
Why?
Influenza, Human
1
2015
86
0.110
Why?
Respiratory Tract Infections
1
2015
83
0.110
Why?
Anemia, Macrocytic
1
2013
2
0.110
Why?
Motor Activity
1
2014
224
0.110
Why?
Cluster Analysis
2
2010
209
0.110
Why?
Prescription Drug Misuse
1
2013
34
0.110
Why?
Cytogenetic Analysis
1
2013
74
0.110
Why?
Base Sequence
3
2010
622
0.100
Why?
Aging
1
2018
692
0.100
Why?
Endpoint Determination
2
2013
26
0.100
Why?
Depression
2
2016
577
0.100
Why?
Prevalence
3
2018
967
0.100
Why?
Self Report
1
2014
206
0.100
Why?
RNA, Messenger
4
2021
1085
0.100
Why?
Genomics
1
2014
238
0.100
Why?
Heart Defects, Congenital
1
2018
603
0.100
Why?
Neurology
1
2012
42
0.100
Why?
Chromosome Deletion
2
2013
134
0.100
Why?
Pain Perception
1
2011
5
0.100
Why?
Organotechnetium Compounds
1
2011
7
0.090
Why?
Pennsylvania
1
2011
36
0.090
Why?
Haploinsufficiency
1
2011
14
0.090
Why?
Mosaicism
1
2011
18
0.090
Why?
Libido
3
2016
9
0.090
Why?
Genotyping Techniques
1
2011
19
0.090
Why?
Blotting, Northern
1
2011
109
0.090
Why?
Cysteine
1
2011
50
0.090
Why?
Analgesia
1
2011
13
0.090
Why?
Microbial Sensitivity Tests
2
2010
268
0.090
Why?
RNA, Small Interfering
2
2008
208
0.090
Why?
Encephalitis, Viral
1
2010
6
0.090
Why?
Neoplastic Stem Cells
2
2022
97
0.090
Why?
Genome-Wide Association Study
1
2011
163
0.090
Why?
Radiopharmaceuticals
1
2011
202
0.090
Why?
Typhoid Fever
1
2010
2
0.090
Why?
Salmonella typhi
1
2010
3
0.090
Why?
Dengue
1
2010
3
0.090
Why?
Viremia
1
2010
21
0.090
Why?
Bacterial Typing Techniques
1
2010
34
0.080
Why?
Daunorubicin
2
2022
11
0.080
Why?
Reproducibility of Results
2
2016
1181
0.080
Why?
WT1 Proteins
1
2009
4
0.080
Why?
Cytarabine
2
2022
37
0.080
Why?
Antibodies, Viral
1
2010
93
0.080
Why?
DNA, Bacterial
1
2010
165
0.080
Why?
Outpatients
2
2024
121
0.080
Why?
Viral Nonstructural Proteins
1
2010
58
0.080
Why?
Chronic Disease
5
2011
573
0.080
Why?
Cohort Studies
2
2016
1451
0.080
Why?
Guidelines as Topic
1
2009
110
0.080
Why?
Brain
1
2017
1318
0.080
Why?
Chromosomes, Human, Pair 3
1
2008
18
0.070
Why?
Pedigree
1
2008
119
0.070
Why?
Saccharomyces cerevisiae Proteins
1
2009
142
0.070
Why?
Opioid-Related Disorders
1
2012
392
0.070
Why?
Social Participation
2
2019
5
0.070
Why?
Chromosomes, Human, Pair 6
1
2007
14
0.070
Why?
Wilms Tumor
1
2007
18
0.070
Why?
Genes, Tumor Suppressor
1
2007
73
0.070
Why?
Oxycodone
1
2007
27
0.070
Why?
Amino Acid Sequence
1
2008
575
0.070
Why?
Health Care Surveys
1
2007
208
0.070
Why?
Molecular Sequence Data
1
2008
760
0.070
Why?
Ubiquitin-Protein Ligases
1
2007
93
0.070
Why?
Focus Groups
2
2023
193
0.070
Why?
DNA Helicases
1
2008
147
0.070
Why?
Mice
4
2023
5659
0.070
Why?
Cell Differentiation
2
2021
640
0.060
Why?
Models, Biological
1
2009
717
0.060
Why?
Kidney Neoplasms
1
2007
174
0.060
Why?
Cell Line
1
2008
997
0.060
Why?
Comorbidity
1
2007
621
0.060
Why?
Graft vs Host Disease
1
2005
85
0.060
Why?
Tacrolimus
1
2005
54
0.060
Why?
Transcriptome
2
2017
314
0.060
Why?
Insulin, Isophane
1
2024
1
0.060
Why?
DNA
1
2008
534
0.060
Why?
Glomerular Filtration Rate
1
2025
119
0.060
Why?
Autoimmune Diseases
1
2005
78
0.060
Why?
Patient Acceptance of Health Care
2
2024
342
0.060
Why?
Follow-Up Studies
2
2020
2231
0.060
Why?
Erectile Dysfunction
2
2016
90
0.060
Why?
Amyotrophic Lateral Sclerosis
1
2024
34
0.060
Why?
Nucleosome Assembly Protein 1
1
2024
1
0.060
Why?
Hospice Care
1
2024
27
0.060
Why?
Minor Histocompatibility Antigens
1
2024
17
0.060
Why?
Hyperglycemia
1
2024
81
0.060
Why?
Factor VIII
1
2024
23
0.060
Why?
Myeloid-Lymphoid Leukemia Protein
1
2024
14
0.060
Why?
Proto-Oncogenes
1
2024
27
0.060
Why?
DEAD-box RNA Helicases
1
2024
33
0.050
Why?
Retinoblastoma-Binding Protein 2
1
2023
6
0.050
Why?
Real-Time Polymerase Chain Reaction
2
2015
179
0.050
Why?
Nuclear Pore Complex Proteins
1
2023
11
0.050
Why?
Proto-Oncogene Proteins c-ret
1
2024
32
0.050
Why?
Health Care Costs
1
2024
171
0.050
Why?
Autoantibodies
1
2024
114
0.050
Why?
Trauma Centers
1
2025
199
0.050
Why?
CpG Islands
1
2023
107
0.050
Why?
Hypoglycemic Agents
1
2024
174
0.050
Why?
Ambulatory Care
1
2024
243
0.050
Why?
Treatment Failure
1
2003
120
0.050
Why?
Apoptosis
1
2008
1092
0.050
Why?
Computational Biology
1
2024
194
0.050
Why?
Disease Management
1
2024
179
0.050
Why?
Hemorrhage
1
2024
195
0.050
Why?
Predictive Value of Tests
1
2025
924
0.050
Why?
Insulin
1
2024
464
0.050
Why?
Vaccination
1
2024
275
0.050
Why?
Algorithms
2
2017
624
0.050
Why?
Parkinson Disease
1
2024
161
0.050
Why?
Proto-Oncogene Proteins c-cbl
1
2022
3
0.050
Why?
Core Binding Factor beta Subunit
1
2021
3
0.050
Why?
Blood Coagulation
1
2002
59
0.050
Why?
Myosin Heavy Chains
1
2021
20
0.050
Why?
Longitudinal Studies
2
2019
732
0.050
Why?
RNA
1
2022
164
0.050
Why?
Recombinant Proteins
1
2003
477
0.050
Why?
Qualitative Research
1
2023
351
0.050
Why?
Gene Expression Regulation, Leukemic
1
2021
29
0.040
Why?
Enhancer Elements, Genetic
1
2021
57
0.040
Why?
Acetylation
1
2021
94
0.040
Why?
Alzheimer Disease
1
2024
316
0.040
Why?
RNA-Binding Proteins
1
2021
116
0.040
Why?
Trans-Activators
1
2021
135
0.040
Why?
Emergency Service, Hospital
1
2024
489
0.040
Why?
Genetic Association Studies
1
2021
118
0.040
Why?
HEK293 Cells
1
2021
209
0.040
Why?
Mice, Inbred BALB C
1
2021
293
0.040
Why?
Up-Regulation
1
2021
446
0.040
Why?
Cell Transformation, Neoplastic
1
2021
182
0.040
Why?
Receptors, GABA-A
1
2019
12
0.040
Why?
Pandemics
1
2024
553
0.040
Why?
Risk Assessment
2
2015
1268
0.040
Why?
Oxidative Stress
1
2024
770
0.040
Why?
Cell Line, Tumor
1
2023
1393
0.040
Why?
Hematopoietic Stem Cells
1
2021
197
0.040
Why?
Protein Binding
1
2021
648
0.040
Why?
Hematopoietic Stem Cell Transplantation
1
2024
580
0.040
Why?
Histones
1
2021
294
0.040
Why?
Emotions
2
2014
167
0.040
Why?
Combined Modality Therapy
1
2020
640
0.040
Why?
Patient Selection
2
2010
257
0.040
Why?
Etoposide
1
2017
77
0.040
Why?
Drug Administration Routes
1
2017
10
0.030
Why?
Erythroid Cells
1
2017
5
0.030
Why?
Genes, Dominant
1
2017
19
0.030
Why?
Erythropoiesis
1
2017
15
0.030
Why?
Genes, X-Linked
1
2017
7
0.030
Why?
Drug Monitoring
1
2017
81
0.030
Why?
Models, Genetic
1
2017
166
0.030
Why?
Protein-Tyrosine Kinases
1
1996
85
0.030
Why?
Cognition
1
2019
342
0.030
Why?
Statistics as Topic
1
2016
86
0.030
Why?
Prostate-Specific Antigen
1
2016
44
0.030
Why?
Basic Reproduction Number
1
2015
1
0.030
Why?
Reference Values
1
2016
302
0.030
Why?
Promoter Regions, Genetic
1
2017
455
0.030
Why?
Meteorological Concepts
1
2015
1
0.030
Why?
Congresses as Topic
1
2015
47
0.030
Why?
Pharynx
1
2015
31
0.030
Why?
Family Health
1
2015
76
0.030
Why?
China
1
2015
91
0.030
Why?
Androstadienes
1
2014
11
0.030
Why?
DNA, Viral
1
2015
134
0.030
Why?
Nitriles
1
2014
52
0.030
Why?
Sample Size
1
2014
39
0.030
Why?
Epigenesis, Genetic
1
2017
371
0.030
Why?
Publishing
1
2014
40
0.030
Why?
Child Health Services
1
2015
78
0.030
Why?
Methylation
1
2014
117
0.030
Why?
Gait
1
2014
89
0.030
Why?
Acupuncture Points
1
2013
3
0.030
Why?
Population
1
2013
9
0.030
Why?
Triazoles
1
2014
113
0.030
Why?
Clinical Trials, Phase III as Topic
1
2013
47
0.030
Why?
Chromosomes, Human, Pair 5
1
2013
15
0.030
Why?
Waiting Lists
1
2013
59
0.030
Why?
Cells, Cultured
1
2017
1563
0.030
Why?
Substance Abuse Detection
1
2013
92
0.030
Why?
Terminology as Topic
1
2013
67
0.030
Why?
Models, Statistical
1
2014
224
0.030
Why?
Risk
1
2013
325
0.030
Why?
Immunologic Factors
1
2013
113
0.020
Why?
Internationality
1
2012
39
0.020
Why?
Socioeconomic Factors
1
2013
591
0.020
Why?
Thalidomide
1
2013
375
0.020
Why?
Virology
1
2010
6
0.020
Why?
Coma
1
2010
16
0.020
Why?
Cryptococcus gattii
1
2010
1
0.020
Why?
Flucytosine
1
2010
14
0.020
Why?
DNA Gyrase
1
2010
4
0.020
Why?
Nepal
1
2010
11
0.020
Why?
Reagent Kits, Diagnostic
1
2010
16
0.020
Why?
Immunoassay
1
2010
20
0.020
Why?
High-Throughput Screening Assays
1
2010
35
0.020
Why?
Amphotericin B
1
2010
110
0.020
Why?
Haplotypes
1
2010
83
0.020
Why?
RNA, Viral
1
2010
107
0.020
Why?
Point-of-Care Systems
1
2010
58
0.020
Why?
Random Allocation
1
2010
284
0.020
Why?
Drug Administration Schedule
1
2010
373
0.020
Why?
Disease-Free Survival
1
2009
439
0.020
Why?
Retroviridae
1
2008
9
0.020
Why?
Probability Theory
1
2008
2
0.020
Why?
Anaerobiosis
1
2008
19
0.020
Why?
Transduction, Genetic
1
2008
45
0.020
Why?
Least-Squares Analysis
1
2008
39
0.020
Why?
Gene Knockdown Techniques
1
2008
104
0.020
Why?
Sensitivity and Specificity
1
2010
855
0.020
Why?
Ankyrin Repeat
1
2007
2
0.020
Why?
Antifungal Agents
1
2010
342
0.020
Why?
Mice, Mutant Strains
1
2007
69
0.020
Why?
Pain Clinics
1
2007
4
0.020
Why?
Signal Transduction
1
2014
1608
0.020
Why?
Delayed-Action Preparations
1
2007
55
0.020
Why?
Survival Rate
1
2009
906
0.020
Why?
Bacterial Proteins
1
2010
351
0.020
Why?
Multivariate Analysis
1
2008
583
0.020
Why?
Fibroblasts
1
2008
338
0.020
Why?
Activities of Daily Living
1
2007
175
0.020
Why?
Absorption
1
2005
22
0.020
Why?
Patient Satisfaction
1
2007
276
0.020
Why?
Analysis of Variance
1
2007
549
0.020
Why?
Oxygen
1
2008
319
0.020
Why?
Administration, Topical
1
2005
67
0.020
Why?
Mental Health
1
2007
225
0.010
Why?
Bone Marrow Transplantation
1
2005
135
0.010
Why?
Skin Diseases
1
2005
126
0.010
Why?
Genetic Predisposition to Disease
1
2007
507
0.010
Why?
Gene Expression Regulation, Neoplastic
1
2007
831
0.010
Why?
Blood Coagulation Tests
1
2002
20
0.010
Why?
World Health Organization
1
2002
50
0.010
Why?
Farrar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description